GTC Biotherapeutics (fka GTCB)

[investorjd]

I upped my holding of GTCB by 30% today at $0.40.

The time to buy Biotech stocks is when nobody wants them, assuming they still have value. And GTCB has value in multiple areas.

The moves in the pps will be many and huge when the BLA submission is complete and priority review is granted, formation of further partnerships with FoB’s, with FDA approval of ATryn, and positive results from Ph II trial on DIC associated with severe sepsis.

This stock at this price represents a 10 bagger over the next year or two.

The risk is if the FDA will not accept these transgenic therapeutic proteins. To me they appear to be an important treatment option for the medical community.